Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Additional Recalls for Antibiotic
01/15/2021
More cephalexin products have been voluntarily recalled by Ascend Laboratories after unidentified impurities were observed in the product.
More cephalexin products have been voluntarily recalled by Ascend Laboratories after unidentified impurities were observed in the product.
More cephalexin products have...
01/15/2021
Pharmacy Learning Network
News
Pain Injections Recalled
01/15/2021
Potentially defective syringe caps that could affect drug sterility have prompted SCA Pharmaceuticals to recall several fentanyl products.
Potentially defective syringe caps that could affect drug sterility have prompted SCA Pharmaceuticals to recall several fentanyl products.
Potentially defective syringe...
01/15/2021
Pharmacy Learning Network

Advertisement

News
Antibiotic Recalled
01/08/2021
A Class II recall is active for a prescription antibiotic used to treat a wide variety of bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat a wide variety of bacterial infections.
A Class II recall is active for...
01/08/2021
Pharmacy Learning Network
News
Pain Medication Recalled
01/08/2021
Particulate matter discovered in reserve sample vials has led Fresenius Kabi USA to recall nearly a half million vials of ketorolac tromethamine injection.
Particulate matter discovered in reserve sample vials has led Fresenius Kabi USA to recall nearly a half million vials of ketorolac tromethamine injection.
Particulate matter discovered in...
01/08/2021
Pharmacy Learning Network
News
Combination Antibiotic Recalled Over Sterility Concerns
01/08/2021
Sterility concerns have prompted Merck Sharp & Dohme to issue a voluntary recall of all unexpired lots of Zerbaxa (ceftolozane and tazobactam) 1.5 g/vial for injection.
Sterility concerns have prompted Merck Sharp & Dohme to issue a voluntary recall of all unexpired lots of Zerbaxa (ceftolozane and tazobactam) 1.5 g/vial for injection.
Sterility concerns have prompted...
01/08/2021
Pharmacy Learning Network

Advertisement

News
Children’s Hospitals Are Partly to Blame as Superbugs Increasingly Attack Kids
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
Antianxiety Agent Recalled
12/30/2020
Morton Grove Pharmaceuticals Inc. is pulling 127,392 bottles of hydroxyzine hydrochloride oral solution after impurities were detected during routine testing.
Morton Grove Pharmaceuticals Inc. is pulling 127,392 bottles of hydroxyzine hydrochloride oral solution after impurities were detected during routine testing.
Morton Grove Pharmaceuticals...
12/30/2020
Pharmacy Learning Network
News
Chronic Kidney Disease Drug Recalled
12/30/2020
The FDA has issued a recall for a prescription drug used to treat iron deficiency anemia in adults with chronic kidney disease not on dialysis.
The FDA has issued a recall for a prescription drug used to treat iron deficiency anemia in adults with chronic kidney disease not on dialysis.
The FDA has issued a recall for...
12/30/2020
Pharmacy Learning Network

Advertisement

News
Anesthetic Injection Recalled
12/30/2020
A Class II recall is active for a prescription injection used to produce local or regional anesthesia or analgesia for surgery and other medical procedures, childbirth, and dental work.
A Class II recall is active for a prescription injection used to produce local or regional anesthesia or analgesia for surgery and other medical procedures, childbirth, and dental work.
A Class II recall is active for...
12/30/2020
Pharmacy Learning Network
News
GERD Drug Recalled
12/23/2020
The FDA has issued a Class II recall for a prescription-strength medication used to treat stomach and esophagus problems such as gastroesophageal reflux disease and ulcers.
The FDA has issued a Class II recall for a prescription-strength medication used to treat stomach and esophagus problems such as gastroesophageal reflux disease and ulcers.
The FDA has issued a Class II...
12/23/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use